CEO SUMMARY: Expect the merger of AutoCyte, Inc. and NeoPath, Inc. to inaugurate a new market cycle for automated cytology systems. FDA approval of AutoCyte’s liquid preparation system, called PREP™, sets the stage for intensified marketing battles between the AutoCyte/NeoPath consortium and Cytyc Corporation. Clinical laboratories should benefit from this competition. When the recently-announced merger […]
Surprise Merger Changes Cytology Marketplace
AutoCyte and NeoPath are joining forces to offer a unified automated cytology solution
- By Robert Michel
- > From the Volume VI No. 9 - June 28, 1999 Issue
